Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 136470 78 5. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107641122B reveals a scalable crystallization method replacing chromatography, offering high-purity abacavir intermediates with significant cost reduction and supply chain reliability for global API manufacturers.
Patent CN101522680B reveals a novel base-catalyzed deprotection route for Abacavir, offering superior yield and purity for pharmaceutical intermediate manufacturing.